An experimental weight loss drug named Qnexa is showing promise as its researchers found out that individuals suffering from obesity have shed off an a cumulative average of 22 pounds in more than one year. At the same time, the said medication was also able to significantly decrease the levels and readings of both cholesterol and blood pressure.
Accordingly, the medicine is a combination of two drugs namely Phentermine and Topiramate. While the former is acknowledged especially in the United States as a drug for losing weight, the latter is most noted for its role in cases of migraine and epilepsy
Even if Qnexa’s use was disapproved lately by the Food and Drug Administration of the US because of insufficient information on the risks as regards heart ailments and birth defects, Dr. Kishore Gadde, the lead author of the study suggests that the use of the experimental weight loss drug, if given together with proper and adequate lifestyle counseling may be an important tool to curb obesity.
